PRESS RELEASE published on 01/23/2024 at 11:59, 9 months 29 days ago Linde Signs Record Number of Small On-Site Projects in 2023 Linde plc has announced a record number of new small on-site projects for 2023, marking its fourth consecutive year of growth. The projects, totaling $270 million in capex, focus on the supply of nitrogen and oxygen using Linde's proprietary ECOVAR® technology, designed for efficiency and environmental sustainability. The company's NITRONTM on-site nitrogen plants are in high demand across sectors such as battery storage for consumer electronics and electric vehicles, while the VITRON® on-site oxygen plant projects cater to the glass and metals industries. Linde's oxy-fuel applications aim to reduce customers' fuel consumption and emissions, contributing to the project wins. For more information, visit linde.com. Linde Plc Small On-site Projects Nitrogen And Oxygen Supply ECOVAR Technology Oxy-fuel Applications
PRESS RELEASE published on 10/26/2023 at 11:45, 1 year ago Linde plc: Linde Reports Third Quarter 2023 Results (Earnings Release Tables Attached)
PRESS RELEASE published on 10/25/2023 at 11:59, 1 year ago Linde to Supply Industrial Gases to Indian Oil’s Panipat Refinery
PRESS RELEASE published on 10/23/2023 at 15:04, 1 year ago Linde plc: Linde Declares Dividend in Fourth Quarter 2023 and New $15 Billion Share Repurchase Program
PRESS RELEASE published on 10/04/2023 at 12:01, 1 year 1 month ago Linde Announces Third Quarter 2023 Earnings and Conference Call Schedule
PRESS RELEASE published on 07/28/2023 at 11:59, 1 year 3 months ago Linde Publishes 2022 Sustainable Development Report
PRESS RELEASE published on 07/27/2023 at 11:58, 1 year 3 months ago Linde plc: Linde Reports Second-Quarter 2023 Results (Earnings Release Tables Attached)
PRESS RELEASE published on 07/24/2023 at 19:16, 1 year 3 months ago Linde plc: Linde Declares Dividend in Third Quarter 2023
PRESS RELEASE published on 07/20/2023 at 12:01, 1 year 4 months ago FTSE4Good Index Includes Linde for Eighth Consecutive Year
PRESS RELEASE published on 07/17/2023 at 12:00, 1 year 4 months ago Linde Signs Landmark Renewable Energy Agreements in Brazil
Published on 11/22/2024 at 00:00, 2 hours 9 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 4 hours 4 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 4 hours 19 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 5 hours 54 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 5 hours 59 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 7 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 7 hours 33 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 8 hours 10 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 8 hours 17 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 8 hours 17 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 19 hours 11 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 6 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 8 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 8 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 18 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo